Raptiva (efalizumab) sales are now suspended in Canada due to the risk of fatal opportunistic infections

Raptiva (efalizumab) sales are now suspended in Canada due to the risk of fatal opportunistic infections....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login